jurkat lucia nfat cd16 cells (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
97
Structured Review
InvivoGen
jurkat lucia nfat cd16 cells
Jurkat Lucia Nfat Cd16 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 98 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd16/Jurkat-Lucia+NFAT-CD16-Low+Cells/pmc13183376-63-5-9
Average 97 stars, based on 98 article reviews
Jurkat Lucia Nfat Cd16 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 98 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd16/Jurkat-Lucia+NFAT-CD16-Low+Cells/pmc13183376-63-5-9
Average 97 stars, based on 98 article reviews
jurkat lucia nfat cd16 cells - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
other:Article Title: Simultaneous solubility-enhancing domain removal and target purification using the Npu split intein. Article Snippet: Values for the relative abundance of deconvoluted masses were normalized using the Min-Max normalization equation and plotted using MATLAB R2024b. Article Title: Human neutralizing antibodies targeting the Measles virus hemagglutinin and fusion surface proteins Article Snippet: HEK 293F cells were maintained in FreeStyle293 Expression Medium (Gibco) at 37°C with 5% CO 2 . Article Title: Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers Article Snippet: To evaluate the silencing of ADCC activity by the N297A mutation, an ADCC reporter assay was performed using Binding Assay:Article Title: Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Article Snippet: Background: Death receptor 3 (DR3; also termed tumor necrosis factor receptor superfamily member 25 [TNFRSF25]) is the sole functional receptor for tumor necrosis factor (TNF)–like cytokine 1A (TL1A) and is constitutively expressed on effector lymphoid cells in peripheral blood and in both inflamed and adjacent noninflamed tissues.. Excessive DR3 signaling contributes to chronic inflammation in inflammatory bowel disease (IBD).. While clinical trials of anti-TL1A antibodies have demonstrated efficacy in ulcerative colitis and Crohn disease, the stable expression pattern of DR3 suggests that receptor blockade may more effectively and durably inhibit TL1A-driven proinflammatory signaling and limit disease propagation. Activity Assay:Article Title: Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Article Snippet: Background: Death receptor 3 (DR3; also termed tumor necrosis factor receptor superfamily member 25 [TNFRSF25]) is the sole functional receptor for tumor necrosis factor (TNF)–like cytokine 1A (TL1A) and is constitutively expressed on effector lymphoid cells in peripheral blood and in both inflamed and adjacent noninflamed tissues.. Excessive DR3 signaling contributes to chronic inflammation in inflammatory bowel disease (IBD).. While clinical trials of anti-TL1A antibodies have demonstrated efficacy in ulcerative colitis and Crohn disease, the stable expression pattern of DR3 suggests that receptor blockade may more effectively and durably inhibit TL1A-driven proinflammatory signaling and limit disease propagation. Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation Article Snippet: The percentage of antibody remaining bound to h4-1BB was plotted, and the half-maximal inhibitory concentration (IC 50 ) values were calculated using GraphPad Prism software. .. ADCC reporter activity was assessed using Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation Article Snippet: The percentage of antibody remaining bound to h4-1BB was plotted, and the half-maximal inhibitory concentration (IC50) values were calculated using GraphPad Prism software. .. Antibody-dependent In Vitro:Article Title: Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Article Snippet: Background: Death receptor 3 (DR3; also termed tumor necrosis factor receptor superfamily member 25 [TNFRSF25]) is the sole functional receptor for tumor necrosis factor (TNF)–like cytokine 1A (TL1A) and is constitutively expressed on effector lymphoid cells in peripheral blood and in both inflamed and adjacent noninflamed tissues.. Excessive DR3 signaling contributes to chronic inflammation in inflammatory bowel disease (IBD).. While clinical trials of anti-TL1A antibodies have demonstrated efficacy in ulcerative colitis and Crohn disease, the stable expression pattern of DR3 suggests that receptor blockade may more effectively and durably inhibit TL1A-driven proinflammatory signaling and limit disease propagation. Functional Assay:Article Title: Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Article Snippet: Background: Death receptor 3 (DR3; also termed tumor necrosis factor receptor superfamily member 25 [TNFRSF25]) is the sole functional receptor for tumor necrosis factor (TNF)–like cytokine 1A (TL1A) and is constitutively expressed on effector lymphoid cells in peripheral blood and in both inflamed and adjacent noninflamed tissues.. Excessive DR3 signaling contributes to chronic inflammation in inflammatory bowel disease (IBD).. While clinical trials of anti-TL1A antibodies have demonstrated efficacy in ulcerative colitis and Crohn disease, the stable expression pattern of DR3 suggests that receptor blockade may more effectively and durably inhibit TL1A-driven proinflammatory signaling and limit disease propagation. Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation Article Snippet: The percentage of antibody remaining bound to h4-1BB was plotted, and the half-maximal inhibitory concentration (IC50) values were calculated using GraphPad Prism software. .. Antibody-dependent ADCC Assay:Article Title: FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation Article Snippet: The percentage of antibody remaining bound to h4-1BB was plotted, and the half-maximal inhibitory concentration (IC50) values were calculated using GraphPad Prism software. .. Antibody-dependent |